Erika A. Currier

1.0k citations

26 papers · 851 indexed · h-index 17

Cellular and Molecular Neuroscience top 5%
- Neuropeptides and Animal Physiology 4
Molecular Biology
- Receptor Mechanisms and Signaling 7
Process Chemistry and Technology
Pharmacology top 10%
- Apelin-related biomedical research 5
Endocrine and Autonomic Systems
Surgery
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 6
Endocrinology, Diabetes and Metabolism
- Hormonal Regulation and Hypertension 5
Neurology
- Neuroblastoma Research and Treatments 4
Materials Chemistry
- Thermal Expansion and Ionic Conductivity 3
Genetics
- Estrogen and related hormone effects 3

Co-authors: Uli Hacksell Ethan S. Burstein Mark R. Brann Roger Olsson Tracy A. Spalding Terri Messier Carol Trotter Donghui Li
Cited by: Cellular and Molecular Neuroscience Molecular Biology Process Chemistry and Technology
Journals: Oncogene (1 paper)Journal of Medicinal Chemistry (5 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)
Partner nations: United States Sweden Ireland

In The Last Decade

Erika A. Currier

26 papers receiving 817 citations

Peers

Countries citing papers authored by Erika A. Currier

Since Specialization

Citations

This map shows the geographic impact of Erika A. Currier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika A. Currier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika A. Currier more than expected).

Fields of papers citing papers by Erika A. Currier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika A. Currier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika A. Currier. The network helps show where Erika A. Currier may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Erika A. Currier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erika A. Currier Line = papers co-authored together Erika A. Currier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	PCI-24781 (abexinostat), a novel histone deacetylase inhibitor, induces reactive oxygen species-dependent apoptosis and is synergistic with bortezomib in neuroblastoma PubMed ·Giselle L. Saulnier Sholler,Erika A. Currier,Akshita Dutta,Marni A. Slavik,Sharon Illenye,Maria C. Mendonça,Julie A. Dragon,Stephen S. Roberts,Jeffrey P. Bond	2013	21
2	A Pilot Trial Testing the Feasibility of Using Molecular-Guided Therapy in Patients with Recurrent Neuroblastoma Journal of Cancer Therapy ·Giselle L. Saulnier Sholler,William S. Ferguson,Genevieve Bergendahl,Erika A. Currier,Shannon R. Lenox,Jeffrey P. Bond,Marni A. Slavik,William Roberts,Deanna Mitchell,Don Eslin,Jacqueline M. Kraveka,Joel A. Kaplan,Nehal S. Parikh,Suman Malempati,Gina Hanna,Emily Eugster,David Cherba,J. Miller,Craig P. Webb	2012	12
3	Single Tumor Imaging with Multiple Antibodies Targeting Different Antigens BioTechniques ·Yujing Sun,Girja S. Shukla,Stephanie C. Pero,Erika A. Currier,Giselle L. Saulnier Sholler,David N. Krag	2012	2
4	Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: A novel therapeutic agent for neuroblastoma Molecular Carcinogenesis ·Don Eslin,Umesh T. Sankpal,Chris Lee,Robert M. Sutphin,Pius Maliakal,Erika A. Currier,Giselle L. Saulnier Sholler,Moeez Khan,Riyaz Basha	2011	27
5	Oral RKS262 reduces tumor burden in a neuroblastoma xenograft animal model and mediates cytotoxicity through SAPK/JNK and ROS activation in vitro Cancer Biology & Therapy ·Ajay Singh,Lee Dorf,Angelica M. DeMartino,Sharon Illenye,Karen Koto,Erika A. Currier,Takamaru Ashikaga,Kyu Kwang Kim,Laurent Brard,Giselle L. Saulnier Sholler	2011	8
6	Discovery of a class of calcium sensing receptor positive allosteric modulators; 1-(benzothiazol-2-yl)-1-phenylethanols Bioorganic & Medicinal Chemistry Letters ·Magnus Gustafsson,Jacob Jensen,Sine Mandrup Bertozzi,Erika A. Currier,Jian-Nong Ma,Ethan S. Burstein,Roger Olsson	2010	8
7	Optimization of isochromanone based urotensin II receptor agonists Bioorganic & Medicinal Chemistry ·Fredrik Lehmann,Erika A. Currier,Roger Olsson,Jian-Nong Ma,Ethan S. Burstein,Uli Hacksell,Kristina Luthman	2010	11
8	Novel and potent small-molecule urotensin II receptor agonists Bioorganic & Medicinal Chemistry ·Fredrik Lehmann,Erika A. Currier,Bryan Clemons,Lars Kristian Hansen,Roger Olsson,Uli Hacksell,Kristina Luthman	2009	6
9	Discovery of non-peptidergic MrgX1 and MrgX2 receptor agonists and exploration of an initial SAR using solid-phase synthesis Bioorganic & Medicinal Chemistry Letters ·Leila Malik,Nicholas M. Kelly,Jian-Nong Ma,Erika A. Currier,Ethan S. Burstein,Roger Olsson	2009	17
10	Identification of novel selective V2 receptor non-peptide agonists Biochemical Pharmacology ·Andria L. Del Tredici,K.E. Vanover,A. Knapp,Sine Mandrup Bertozzi,Norman Nash,Ethan S. Burstein,Jelveh Lameh,Erika A. Currier,Robert E. Davis,Mark R. Brann,Nina Mohell,Roger Olsson,Fabrice Piu	2008	5
11	Identification of the First Synthetic Steroidogenic Factor 1 Inverse Agonists: Pharmacological Modulation of Steroidogenic Enzymes Molecular Pharmacology ·Andria L. Del Tredici,Carsten Andersen,Erika A. Currier,Steven R Ohrmund,Luke C Fairbain,Birgitte W. Lund,Norman Nash,Roger Olsson,Fabrice Piu	2007	35
12	Identification of the Atypical L-Type Ca2+ Channel Blocker Diltiazem and Its Metabolites As Ghrelin Receptor Agonists Molecular Pharmacology ·Jian-Nong Ma,Hans H. Schiffer,A. Knapp,Jean Wang,Kenneth K. Wong,Erika A. Currier,Michelle Owens,Norman Nash,Luis R. Gardell,Mark R. Brann,Roger Olsson,Ethan S. Burstein	2007	7
13	Design, parallel synthesis and SAR of novel urotensin II receptor agonists European Journal of Medicinal Chemistry ·Fredrik Lehmann,Lisa Lake,Erika A. Currier,Roger Olsson,Uli Hacksell,Kristina Luthman	2006	33
14	Integrative Functional Assays, Chemical Genomics and High Throughput Screening: Harnessing Signal Transduction Pathways to a Common HTS Readout Current Pharmaceutical Design ·Ethan S. Burstein,Fabrice Piu,Jian‐Nong Ma,Jacques T. Weissman,Erika A. Currier,Norman Nash,David M. Weiner,Tracy A. Spalding,Hans H. Schiffer,Andria L. Del Tredici,Mark R. Brann	2006	28
15	Isochromanone-based urotensin-II receptor agonists Bioorganic & Medicinal Chemistry ·Fredrik Lehmann,Erika A. Currier,Roger Olsson,Uli Hacksell,Kristina Luthman	2005	26
16	Identification of novel subtype selective RAR agonists Biochemical Pharmacology ·Fabrice Piu,Natalie K. Gauthier,Roger Olsson,Erika A. Currier,Birgitte W. Lund,Glenn Croston,Uli Hacksell,Mark R. Brann	2005	30
17	Discovery of novel peptide/receptor interactions: identification of PHM-27 as a potent agonist of the human calcitonin receptor Biochemical Pharmacology ·Jian‐Nong Ma,Erika A. Currier,Anthony Essex,Michele Feddock,Tracy A. Spalding,Norman Nash,Mark R. Brann,Ethan S. Burstein	2004	8
18	Discovery of an Ectopic Activation Site on the M₁Muscarinic Receptor Molecular Pharmacology ·Tracy A. Spalding,Carol Trotter,Niels Skjærbæk,Terri Messier,Erika A. Currier,Ethan S. Burstein,Donghui Li,Uli Hacksell,Mark R. Brann	2002	156
19	Discovery of an Ectopic Activation Site on the M1Muscarinic Receptor Molecular Pharmacology ·Tracy A. Spalding,Carol Trotter,Niels Skjærbæk,Terri Messier,Erika A. Currier,Ethan S. Burstein,Donghui Li,Uli Hacksell,Mark R. Brann	2002	19
20	The ras-related GTPase rac1 regulates a proliferative pathway selectively utilized by G-protein coupled receptors Oncogene ·Ethan S. Burstein,Diane J Hesterberg,J. Silvio Gutkind,Mark R. Brann,Erika A. Currier,Terri Messier	1998	23

About Erika A. Currier

Erika A. Currier is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Endocrinology, Diabetes and Metabolism, having authored 26 papers that have together received 851 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (7 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (6 papers), Apelin-related biomedical research (5 papers), Hormonal Regulation and Hypertension (5 papers), Neuroblastoma Research and Treatments (4 papers), Neuropeptides and Animal Physiology (4 papers), Thermal Expansion and Ionic Conductivity (3 papers) and Estrogen and related hormone effects (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (335 citations), Molecular Biology (469 citations) and Process Chemistry and Technology (19 citations). Erika A. Currier has collaborated with scholars based in United States, Sweden and Ireland. Frequent co-authors include Uli Hacksell, Ethan S. Burstein, Mark R. Brann, Roger Olsson, Tracy A. Spalding, Terri Messier, Carol Trotter, Donghui Li, Fabrice Piu and Niels Skjærbæk. Their work appears in journals such as Oncogene, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact